Glenmark Life Sciences
BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
30.83Net Income/employee - trailing 12 month
-Revenue/employee - most recent fiscal year
-Return on investment - most recent fiscal year
20.43Return on average assets - most recent fiscal year
16.96Receivables turnover - most recent fiscal year
2.90Return on investment - trailing 12 month
20.43Return on average assets - trailing 12 month
16.96Inventory turnover - most recent fiscal year
1.58Inventory turnover - trailing 12 month
1.58Revenue/employee - trailing 12 month
-Return on average assets - 5 year average
18.28Net Income/employee - most recent fiscal year
-Return on average equity - trailing 12 month
21.07Receivables turnover - trailing 12 month
2.90Asset turnover - most recent fiscal year
0.82Asset turnover - trailing 12 month
0.82Return on average equity - most recent fiscal year
21.07Return on investment - 5 year average
30.03